Genmab A/S (GMAB) Institutional Ownership

Ownership Summary

Genmab A/S (NASDAQ:GMAB) showed up in the 13F filings of 267 institutional investors as of March 2026.

• They owned 0.0% of outstanding stock in March 2026, up from 0.0% the prior quarter.
• Their total shares held in GMAB increased 16.12% quarter over quarter, and separately, investors owning Genmab A increased 20.27% from a year ago.
• Of these 267 funds, 147 grew their exposure to Genmab A, 92 cut back, and 28 maintained positions.
• In total, institutional investors held 81.79Mn shares in Genmab A as of March 2026, up by 11.36Mn shares quarter on quarter, and up 14.05Mn shares year over year.
• As of March 31, 2026, the biggest holder of Genmab A is Orbis Allan Gray Ltd at 12.93Mn shares, representing 0.0% of shares outstanding.
• The largest buyers of Genmab A for the quarter ending March 2026 were Deep Track Capital, LP (3.66Mn), DEERFIELD MANAGEMENT COMPANY, L.P. (2.46Mn), TWO SIGMA INVESTMENTS, LP (1.44Mn), Franklin Resources Inc (1.16Mn), FIRST TRUST ADVISORS LP (1.13Mn).
• Leading sellers of Genmab A shares for the quarter ending March 2026 were Goldman Sachs Group Inc (1.74Mn), Orbis Allan Gray Ltd (1.49Mn), ALLIANCEBERNSTEIN L.P. (1.32Mn), MARSHALL WACE, LLP (343.44K), LPL Financial LLC (249.38K).
• Per Business Quant, the top 10 investors in GMAB for the quarter ending March 2026 include Orbis Allan Gray Ltd (12.93Mn), ALLIANCEBERNSTEIN L.P. (9.56Mn), Paradigm Biocapital Advisors LP (7.97Mn), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (4.98Mn), BlackRock, Inc. (4.54Mn), RENAISSANCE TECHNOLOGIES LLC (4.41Mn), Deep Track Capital, LP (3.66Mn), HARDING LOEVNER LP (3.23Mn), DEERFIELD MANAGEMENT COMPANY, L.P. (2.46Mn), FIRST TRUST ADVISORS LP (2.46Mn).